November 2023 9 stability) and that, when relevant, bioequivalent products can be interchangeable. Individuals should be also aware of potential different concentrations and formulations of each compound/ medicine, and possible drug combinations present in a commercial product. Additionally, this list is not meant to be used as a reference for dosage regimens, drug interactions, indications or contraindications, adverse effects or description of pharmacologic effects. It does not describe what medicines require monitoring, specific means of disposal/elimination/record keeping or follow-up consultations as the list should not be used as guidance for therapy. Essential medicines are presented in alphabetical order and divided by either drug category (anaesthetic, analgesics, immunomodulators, oncology drugs, sedatives, vaccines, antiparasitics and antimicrobials, including antibacterial, antifungal, antiprotozoal and antiviral drugs) or organ system/specialty (cardiorespiratory and renal, endocrinology, gastrointestinal, neurology, ophthalmology or reproduction). The essential list of medicines for dermatology is presented in other sections of the document (e.g. immunomodulators, antimicrobials, antiparasitics, etc.). Cross-reference between a drug category and an organ system is acknowledged where appropriate. Some veterinary specialties may not be listed as their lists of essential medicines have been merged into another drug category or organ system. CRITERIA FOR SELECTION OF ESSENTIAL MEDICINES Essential medicines are selected with due regard to disease prevalence and public/animal health relevance, evidence of clinical efficacy and safety, and comparative costs and cost-effectiveness. These medicines can be rarely replaced by other medicines and their absence could compromise public/animal health and welfare. The core list presents a list of minimum medicine needs for a basic health care system, listing the most efficacious, safe and costeffective medicines for priority conditions. Priority conditions are selected based on current and estimated future public/ animal health relevance, and potential for safe and cost-effective treatment. The complementary list presents essential medicines for priority diseases, for which advanced diagnostic or monitoring facilities, and/or advanced medical care, and/or advanced training are needed. In case of doubt, medicines may also be listed as complementary based on consistently higher cost or less attractive cost-effectiveness in a variety of settings and wide availability in the profession. ANAESTHETIC, ANALGESIC, SEDATIVE AND EMERGENCY DRUGS (The WSAVA Global Pain Council has published the 2022 WSAVA guidelines for appropriate recognition, assessment and treatment of pain including protocols with different drug availability: https://onlinelibrary.wiley.com/doi/10.1111/jsap.13566 The WSAVA Global Pain Council has published information on the minimum analgesic availability: https://www.wsava.org/WSAVA/ media/Documents/Committee%20 Resources/WSAVA-GPC-Position-minimum-analgesic-availability.pdf Core list 1) α2-Adrenoceptor agonists (xylazine, medetomidine or dexmedetomidine) Sedatives, muscle relaxants and analgesics that are used for premedication and chemical restraint with the benefit of reversibility (if an antagonist such as yohimbine, tolazoline or atipamezole is available). They are used as part of injectable protocols for spay-neuter programmes and may counteract the muscle rigidity produced by ketamine. 2) Adrenaline (epinephrine) Inotrope and vasoactive drug used in the emergency setting during cardiac arrest and/or the management of severe systemic anaphylaxis. 3) Antagonists of α2-adrenoceptors (yohimbine, tolazoline or atipamezole) Reversal of the effects produced by α2-adrenoceptor agonists. Reversal is often required to quicken anaesthetic recovery and manage adverse effects. 4) Anticholinergics (atropine or glycopyrrolate) Anticholinergic drug used for the prevention or treatment of bradycardia in the perioperative period and in the emergency setting during cardiac resuscitation. Topical atropine is used in the treatment of uveitis (see ophthalmology). 5) Benzodiazepines (midazolam or diazepam) Depressants of the central nervous system used for muscle relaxation and anti-seizure therapy. Often administered in combination with ketamine for anaesthetic induction. Midazolam can be administered intramuscularly (IM) as part of spay-neuter anaesthetic protocols. 6) Calcium gluconate or chloride This is used for the intravenous (iv) treatment of hypocalcaemia in dogs and cats, including periparturient hypocalcaemia or as part of treatment of hyperkalaemia. Cardiovascular parameters should be monitored during administration to prevent toxicity. Calcium gluconate is preferred over calcium chloride to avoid irritation associated with perivascular administration. 7) Corticosteroids These drugs are used for hypoadrenocorticism, inflammatory, immune-mediated and neoplastic conditions. 8) Crystalloid solutions These are a mixture of water and electrolytes and may be hypo-, iso-or hypertonic. Isotonic fluids are commonly used to replace metabolic, procedural and ongoing losses (i.e. prevention and treatment of dehydration and hypovolaemia) and to provide maintenance fluid requirements and a source of electrolytes (e.g. dextrose 5%, sodium chloride 0.9%, balanced electrolyte solutions such as lactated Ringer’s or Hartmann’s solution). Hypertonic solutions (e.g. hypertonic saline 7.5%) can be used for the treatment of increased intracranial pressure and in cases of severe hypotension. 9) Dextrose For emergency treatment of hypoglycaemia and fluid supplementation. 10) Dissociative anaesthetics (ketamine or tiletamine-zolazepam) Dissociative anaesthetic with anti-hyperalgesic (i.e. analgesic) properties administered for induction of anaesthesia, chemical restraint and often as part of injectable protocols for spayneuter programmes or disaster medicine. Ketamine must not be Leading Article
RkJQdWJsaXNoZXIy OTc5MDU=